What is the incidence of Naproxen (Nonsteroidal Anti-Inflammatory Drug (NSAID))-induced aseptic meningitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 13, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Incidence of Naproxen-induced Aseptic Meningitis

Naproxen-induced aseptic meningitis is a rare adverse effect, occurring in less than 1% of patients taking this medication, with higher risk in those with underlying autoimmune conditions such as systemic lupus erythematosus. 1, 2

Definition and Clinical Context

Aseptic meningitis is characterized by:

  • Symptoms of meningism (neck stiffness, headache, photophobia) 3
  • Raised numbers of cells in the cerebrospinal fluid (CSF) 3
  • Sterile bacterial culture 3

Epidemiology and Risk Factors

Incidence

  • Drug-induced aseptic meningitis is rare, with NSAIDs being one of the causative agents 3
  • Among NSAIDs that cause aseptic meningitis:
    • Ibuprofen is most frequently implicated 2
    • Naproxen is another common NSAID associated with this condition, but less frequently than ibuprofen 2

Risk Factors

  • Underlying autoimmune diseases, particularly systemic lupus erythematosus (SLE), significantly increase the risk 2, 4
  • Women may be at higher risk than men 4, 5
  • Previous episodes of drug-induced aseptic meningitis increase risk of recurrence 4, 6

Clinical Presentation

Typical symptoms include:

  • Headache (severe) 5
  • Fever 5
  • Neck stiffness (nuchal rigidity) 5
  • Nausea and vomiting 5
  • Photophobia 3

Laboratory findings typically show:

  • CSF pleocytosis (often polymorphonuclear) 5
  • Elevated CSF protein 5
  • Normal CSF glucose 7
  • No evidence of bacterial, fungal, or viral infection 5

Diagnosis

Diagnosis is primarily by exclusion:

  • CSF analysis showing aseptic inflammation 5
  • Negative microbiological studies 5
  • Temporal relationship between naproxen administration and symptom onset 4
  • Resolution of symptoms after drug discontinuation 4, 5
  • Recurrence with rechallenge (though intentional rechallenge is not recommended) 4

Management

The primary management approach is:

  • Immediate discontinuation of naproxen 4, 5
  • Supportive care for symptoms 8
  • Avoidance of all NSAIDs in the same chemical class in severe cases 3
  • Consider alternative pain management options from different drug classes 3

Prognosis

  • Most cases resolve without long-term sequelae after drug discontinuation 2
  • Symptoms typically improve within 24-48 hours of stopping the medication 5
  • Potential complications may include sensorineural hearing loss and tinnitus, which typically resolve after discontinuation 9

Special Considerations

Cross-reactivity

  • Cross-reactivity between NSAIDs has been reported, though it is not universal 3
  • Patients with naproxen-induced aseptic meningitis may also react to other NSAIDs 6, 7

Recurrence

  • Recurrent episodes can occur with repeated exposure to the causative NSAID 4, 6
  • Multiple episodes of aseptic meningitis should prompt investigation of NSAID use, including over-the-counter medications 6

Clinical Pitfalls to Avoid

  • Failing to obtain a complete medication history, including over-the-counter NSAIDs 6
  • Misdiagnosis as infectious meningitis, leading to unnecessary antimicrobial treatment 7
  • Failure to recognize the association between naproxen and aseptic meningitis, particularly in patients with autoimmune conditions 4
  • Not considering drug-induced aseptic meningitis in the differential diagnosis of recurrent meningitis 6

References

Guideline

Drugs Causing Aseptic Meningitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Naproxen-induced recurrent aseptic meningitis.

DICP : the annals of pharmacotherapy, 1991

Research

Aseptic meningitis associated with naproxen.

Drug intelligence & clinical pharmacy, 1988

Guideline

Aseptic Meningitis: Course and Prognosis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.